1.Wang L, Dong Z, Lin W, Gao R, Chen C, Xu J: Molecular characterization of a pedigree carrying the hypertensionassociated mitochondrial tRNAGln T4363C mutation. Molecular medicine reports 2017, 16(5):6029–6033.
2.Shen Y, Peng X, Wang M, Zheng X, Xu G, Lu L, Xu K, Burstrom B, Burstrom K, Wang J: Family member-based supervision of patients with hypertension: a cluster randomized trial in rural China. J Hum Hypertens 2017, 31(1):29–36.
3.Qiu Q, Li R, Jiang P, Xue L, Lu Y, Song Y, Han J, Lu Z, Zhi S, Mo JQ et al: Mitochondrial tRNA mutations are associated with maternally inherited hypertension in two Han Chinese pedigrees. Human mutation 2012, 33(8):1285–1293.
4.Schapira AH: Mitochondrial disease. Lancet (London, England) 2006, 368(9529):70–82.
5.Inaba Y, Chen JA, Bergmann SR: Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012, 220(1):128–133.
6.Liu P, Demple B: DNA repair in mammalian mitochondria: Much more than we thought? Environmental and molecular mutagenesis 2010, 51(5):417–426.
7.Lu Z, Chen H, Meng Y, Wang Y, Xue L, Zhi S, Qiu Q, Yang L, Mo JQ, Guan MX: The tRNAMet 4435A>G mutation in the mitochondrial haplogroup G2a1 is responsible for maternally inherited hypertension in a Chinese pedigree. European journal of human genetics: EJHG 2011, 19(11):1181–1186.
8.Chen H, Sun M, Fan Z, Tong M, Chen G, Li D, Ye J, Yang Y, Zhu Y, Zhu J: Mitochondrial C4375T mutation might be a molecular risk factor in a maternal Chinese hypertensive family under haplotype C. Clin Exp Hypertens 2018, 40(6):518–523.
9.Kirichenko TV, Sobenin IA, Khasanova ZB, Orekhova VA, Melnichenko AA, Demakova NA, Grechko AV, Orekhov AN, Ble Castillo JL, Shkurat TP: Data on association of mitochondrial heteroplasmy and cardiovascular risk factors: Comparison of samples from Russian and Mexican populations. Data Brief 2018, 18:16–21.
10.Deng H, Yuan L: Molecular genetics of congenital nuclear cataract. Eur J Med Genet 2014, 57(2–3):113–122.
11.Zhu HY, Wang SW, Martin LJ, Liu L, Li YH, Chen R, Wang L, Zhang ML, Benson DW: The role of mitochondrial genome in essential hypertension in a Chinese Han population. European journal of human genetics: EJHG 2009, 17(11):1501–1506.
12.Han GX, Song Y, Chen L, Zhai YZ, Dong J, Li TS, Zhu HY: The role of mitochondrial DNA mutations in a Han Chinese population on sepsis pathogenesis. Eur Rev Med Pharmacol Sci 2017, 21(14):3247–3252.
13.Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clinical and experimental hypertension (New York, NY: 1993) 1999, 21(5–6):1009–1060.
14.Liu LS: [2010 Chinese guidelines for the management of hypertension]. Zhonghua xin xue guan bing za zhi 2011, 39(7):579–615.
15.Zhu HY, Wang SW, Liu L, Li YH, Chen R, Wang L, Holliman CJ: A mitochondrial mutation A4401G is involved in the pathogenesis of left ventricular hypertrophy in Chinese hypertensives. European journal of human genetics: EJHG 2009, 17(2):172–178.
16.Liu Y, Li Y, Gao J, Zhu C, Lan Y, Yang J, Li Z, Guan M, Chen Y: Molecular characterization of a Chinese family carrying a novel C4329A mutation in mitochondrial tRNAIle and tRNAGln genes. BMC medical genetics 2014, 15:84.
17.Echem C, Costa TJD, Oliveira V, Giglio Colli L, Landgraf MA, Rodrigues SF, Franco M, Landgraf RG, Santos-Eichler RA, Bomfim GF et al: Mitochondrial DNA: A new driver for sex differences in spontaneous hypertension. Pharmacol Res 2019, 144:142–150.
18.Zhu Y, Gu X, Xu C: Mitochondrial DNA 7908–8816 region mutations in maternally inherited essential hypertensive subjects in China. BMC Med Genomics 2018, 11(1):89.
19.Ingman M, Gyllensten U: mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic acids research 2006, 34(Database issue):D749–751.
20.Samuels DC, Li C, Li B, Song Z, Torstenson E, Boyd Clay H, Rokas A, Thornton-Wells TA, Moore JH, Hughes TM et al: Recurrent tissue-specific mtDNA mutations are common in humans. PLoS genetics 2013, 9(11):e1003929.
21.Bruno RM, Pucci G, Rosticci M, Guarino L, Guglielmo C, Agabiti Rosei C, Monticone S, Giavarini A, Lonati C, Torlasco C et al: Association Between Lifestyle and Systemic Arterial Hypertension in Young Adults: A National, Survey-Based, Cross-Sectional Study. High Blood Press Cardiovasc Prev 2016, 23(1):31–40.
22.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr. et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (Dallas, Tex: 1979) 2003, 42(6):1206–1252.
23.Chen X, Zhang Y, Xu B, Cai Z, Wang L, Tian J, Liu Y, Li Y: The mitochondrial calcium uniporter is involved in mitochondrial calcium cycle dysfunction: Underlying mechanism of hypertension associated with mitochondrial tRNA(Ile) A4263G mutation. The international journal of biochemistry & cell biology 2016, 78:307–314.
24.Zhou M, Wang M, Xue L, Lin Z, He Q, Shi W, Chen Y, Jin X, Li H, Jiang P et al: A hypertension-associated mitochondrial DNA mutation alters the tertiary interaction and function of tRNA(Leu(UUR)). The Journal of biological chemistry 2017, 292(34):13934–13946.
25.Zhao Y, Chen X, Li H, Zhu C, Li Y, Liu Y: Mitochondrial genome mutations in 13 subunits of respiratory chain complexes in Chinese Han and Mongolian hypertensive individuals. Mitochondrial DNA Part A, DNA mapping, sequencing, and analysis 2018, 29(7):1090–1099.
26.Shimizu A, Mito T, Hayashi C, Ogasawara E, Koba R, Negishi I, Takenaga K, Nakada K, Hayashi J: Transmitochondrial mice as models for primary prevention of diseases caused by mutation in the tRNA(Lys) gene. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(8):3104–3109.
27.Mohanty K, Dada R, Dada T: Neurodegenerative Eye Disorders: Role of Mitochondrial Dynamics and Genomics. Asia-Pacific journal of ophthalmology (Philadelphia, Pa) 2016, 5(4):293–299.
28.Zhou H, Nie K, Qiu R, Xiong J, Shao X, Wang B, Shen L, Lyu J, Fang H: Generation and Bioenergetic Profiles of Cybrids with East Asian mtDNA Haplogroups. Oxid Med Cell Longev 2017, 2017:1062314.
29.Crescenzo R, Bianco F, Falcone I, Coppola P, Liverini G, Iossa S: Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. European journal of nutrition 2013, 52(2):537–545.
30.Singh A, Pezeshki A, Zapata RC, Yee NJ, Knight CG, Tuor UI, Chelikani PK: Diets enriched in whey or casein improve energy balance and prevent morbidity and renal damage in salt-loaded and high-fat-fed spontaneously hypertensive stroke-prone rats. The Journal of nutritional biochemistry 2016, 37:47–59.
31.Rocha MC, Rosa HS, Grady JP, Blakely EL, He L, Romain N, Haller RG, Newman J, McFarland R, Ng YS et al: Pathological mechanisms underlying single large-scale mitochondrial DNA deletions. Annals of neurology 2018, 83(1):115–130.
32.Lehmann D, Tuppen HAL, Campbell GE, Alston CL, Lawless C, Rosa HS, Rocha MC, Reeve AK, Nicholls TJ, Deschauer M et al: Understanding mitochondrial DNA maintenance disorders at the single muscle fibre level. Nucleic acids research 2019.
33.Moskalev AA, Aliper AM, Smit-McBride Z, Buzdin A, Zhavoronkov A: Genetics and epigenetics of aging and longevity. Cell cycle (Georgetown, Tex) 2014, 13(7):1063–1077.
34.Herbers E, Kekalainen NJ, Hangas A, Pohjoismaki JL, Goffart S: Tissue specific differences in mitochondrial DNA maintenance and expression. Mitochondrion 2019, 44:85–92.